Correction to: Cancer Cell Int (2018) 18:135 10.1186/s12935-018-0633-9
Following publication of the original article [1], the authors would like to make an amendment to the Acknowledgements section.
The acknowledgments currently read:
We would like to thank the Simmons Center for Cancer Research for the financial support, Dr. Juan Arroyo (BYU) for his assistance in tissue staining and confocal microscopy, Dr. Himelda Chavez (Universidad Nacional Mayor de San Marcos, Lima, Peru), for her pathology expertise and help in IHC analysis, and a team of surgeons at Utah Valley Regional Medical Center for providing normal and malignant colon tissue.
The corrected acknowledgements would read:
We would like to thank the Simmons Center for Cancer Research for the financial support, Dr. Juan Arroyo (BYU) for his assistance in tissue staining and confocal microscopy, Dr. Himelda Chavez (Universidad Nacional Mayor de San Marcos, Lima, Peru), for her pathology expertise and help in IHC analysis, and a team of surgeons at Utah Valley Regional Medical Center for providing normal and malignant colon tissue. Results from this study are in part based upon data generated by The Cancer Genome Atlas and managed by the United States National Cancer Institute and National Human Genome Research Institute (see http://cancergenome.nih.gov).
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Reference
- 1.Weagel EG, Burrup W, Kovtun R, Velazquez EJ, Felsted AM, Townsend MH, Ence ZE, Suh E, Piccolo SR, Weber KS, Robison RA, O’Neill KL. Membrane expression of thymidine kinase 1 and potential clinical relevance in lung, breast, and colorectal malignancies. Cancer Cell Int. 2018;18:135. doi: 10.1186/s12935-018-0633-9. [DOI] [PMC free article] [PubMed] [Google Scholar]